Functional	O
Dissection	O
of	O
the	O
Enhancer	O
Repertoire	O
in	O
Human	O
Embryonic	O
Stem	O
Cells	O
.	O


Enhancers	O
are	O
genetic	O
elements	O
that	O
regulate	O
spatiotemporal	O
gene	O
expression	O
.	O


Enhancer	O
function	O
requires	O
transcription	O
factor	O
(	O
TF	O
)	O
binding	O
and	O
correlates	O
with	O
histone	O
modifications	O
.	O


However	O
,	O
the	O
extent	O
to	O
which	O
TF	O
binding	O
and	O
histone	O
modifications	O
functionally	O
define	O
active	O
enhancers	O
remains	O
unclear	O
.	O


Here	O
,	O
we	O
combine	O
chromatin	O
immunoprecipitation	O
with	O
a	O
massively	O
parallel	O
reporter	O
assay	O
(	O
ChIP	O
-	O
STARR	O
-	O
seq	O
)	O
to	O
identify	O
functional	O
enhancers	O
in	O
human	O
embryonic	O
stem	O
cells	O
(	O
ESCs	O
)	O
genome	O
-	O
wide	O
in	O
a	O
quantitative	O
unbiased	O
manner	O
.	O


Although	O
active	O
enhancers	O
associate	O
with	O
TFs	O
,	O
only	O
a	O
minority	O
of	O
regions	O
marked	O
by	O
NANOG	O
,	O
OCT4	O
,	O
H3K27ac	O
,	O
and	O
H3K4me1	O
function	O
as	O
enhancers	O
,	O
with	O
activity	O
markedly	O
changing	O
under	O
naive	O
versus	O
primed	O
culture	O
conditions	O
.	O


We	O
identify	O
an	O
enhancer	O
set	O
associated	O
with	O
functions	O
extending	O
to	O
non	O
-	O
ESC	O
-	O
specific	O
processes	O
.	O


Moreover	O
,	O
although	O
transposable	O
elements	O
associate	O
with	O
putative	O
enhancers	O
,	O
only	O
some	O
exhibit	O
activity	O
.	O


Similarly	O
,	O
within	O
super	O
-	O
enhancers	O
,	O
large	O
tracts	O
are	O
non	O
-	O
functional	O
,	O
with	O
activity	O
restricted	O
to	O
small	O
sub	O
-	O
domains	O
.	O


This	O
catalog	O
of	O
validated	O
enhancers	O
provides	O
a	O
valuable	O
resource	O
for	O
further	O
functional	O
dissection	O
of	O
the	O
regulatory	O
genome	O
.	O
